Skip to main content
. Author manuscript; available in PMC: 2023 Jul 12.
Published in final edited form as: Pediatr Blood Cancer. 2021 Aug 28;68(11):e29304. doi: 10.1002/pbc.29304

Figure 1.

Figure 1.

Responses of rhabdomyosarcoma xenografts to SP-2577. Mice received SP-2577 (100 mg/kg daily × 28 days) when tumors were 200–400 mm3). Left panel, Lines show growth of individual tumors, Control (red); SP-2577 treated (blue). The solid (bold) lines show median response; Center panel, Relative tumor volume; Right panel, Kaplan-Meier probability plots for Event-Free Survival (EFS).